Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

The Fast Track designation accelerates troculeucel’s path to U.S. FDA submission for the treatment of patients with moderate Alzheimer’s ...

Most of the affected roles will be in Encoded's technology and early-stage R&D functions. Story Feb. 11 - Inventiva: Low on cash, the French biotech told its workers council that it will be ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity data by online music sources tracked by luminate, radio airplay audience impressions as ...

The top deals were portfolio company Apollo Therapeutics‘ £210 million Series C in September and a pair of approximately £100 million early ... in 40% of all UK biotech venture deals last ...

The report values San Francisco-based Nektar at $17 billion thanks to its multi-billion dollar deal with Bristol-Myers Squibb in February, the largest single product deal in biotech history.

They have specific roles in the organism of which they are part. Their structure is adapted to their function. They are often grouped together with other similar cells in tissues. Root hair cell ...